JAMA Network

•

Kanava • 21 ohjelmaa

Lääketiede

Lääketiede

Viikoittain
Lääketiede

Lääketiede

Joka toinen kuukausi
Lääketiede

Lääketiede

Päivitetty 2.1.
Lääketiede

Lääketiede

Kuukausittain
Lääketiede

Lääketiede

Joka toinen kuukausi
Lääketiede

Lääketiede

Päivitetty 9.2.
Lääketiede

Lääketiede

Joka toinen kuukausi

6 PV SITTEN

Does This Patient Have Volume Overload? The Rational Clinical Examination

Accurate assessment of intravascular volume facilitates decisions about fluid management in patients with volume overload. Author Edmund A. Liles Jr, MD, of the University of Utah joins JAMA Associate Editor David Simel, MD, MHS, to discuss best evidence from physical exam findings including ultrasound, radiographs, and lab studies for determining volume overload in spontaneously breathing patients. Related Content: Does This Patient Have Volume Overload?

6 pv sitten

•

19 min
16.2.

Type 1 Diabetes: Diagnosis and Management

Type 1 diabetes affects approximately 2 million people in the US and 8.4 million people worldwide. Author Desmond Schatz, MD, of the University of Florida joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss current evidence regarding diagnosis and treatment of type 1 diabetes. Related Content: Type 1 Diabetes

16.2.

•

17 min
18.2.

Sunscreen Costs in Association With Sun Protective Behaviors

Interview with Maria L. Wei, MD, PhD, author of Sunscreen Costs in Association With Sun Protective Behaviors. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Sunscreen Costs in Association With Sun Protective Behaviors

18.2.

•

16 min
4 PV SITTEN

Contemporary Outcomes of Cholecystectomy

Interview with Cody Lendon Mullens, MD, MPH, MS, and Dana A. Telem, MD, MPH, authors of Contemporary Outcomes of Cholecystectomy. Hosted by Jamie Coleman, MD. Related Content: Contemporary Outcomes of Cholecystectomy From Safer Cholecystectomy to Smarter Bile Duct Management

4 pv sitten

•

15 min
19.05.2025

Immune Thrombotic Thrombocytopenic Purpura (iTTP)

Immune thrombotic thrombocytopenic purpura (iTTP) is a rare coagulopathic disorder characterized by immune-mediated thrombocytopenia and microangiopathic hemolytic anemia, that can cause life-threatening thrombosis. Coauthor Allyson M. Pishko, MD, MSCE, of the University of Pennsylvania joins JAMA Associate Editor David Simel, MD, MHS, to discuss the recent review of iTTP published in JAMA. Related Content: Immune Thrombotic Thrombocytopenic Purpura

19.05.2025

•

22 min
18.2.

Predicting Adolescent Response to School-Based Mindfulness

Interview with Christian A. Webb, PhD, author of Predicting Adolescent Response to School-Based Mindfulness: A Secondary Analysis of the MYRIAD Trial. Hosted by John Torous, MD. Related Content: Predicting Adolescent Response to School-Based Mindfulness

18.2.

•

19 min
9.2.

Comparative Effectiveness of Brivaracetam, Cenobamate,Lacosamide, and Perampanel in Focal Epilepsy

Interview with Emanuele Cerulli Irelli, MD, PhD, author of Comparative Effectiveness of Brivaracetam, Cenobamate,Lacosamide, and Perampanel in Focal Epilepsy. Hosted by Cynthia E. Armand, MD. Related Content: Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy

9.2.

•

17 min
17.12.2025

WHO Guideline on the Use and Indications of GLP-1 Therapies for the Treatment of Obesity in Adults

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease. WHO recently published a guideline in JAMA on the use and indications of GLP-1 therapies for the treatment of #obesity in adults. Francesca Celletti, MD, PhD, and Ezekiel Emanuel, MD, PhD, join JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss. Related Content: World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults

17.12.2025

•

34 min
21.02.2023

Glioblastoma and Other Primary Brain Malignancies in Adults

Malignant primary brain tumors cause more than 15 000 deaths annually in the US. JAMA Fishbein Fellow Revital Marcus, MD, interviews Ingo Mellinghoff, MD, PhD, neuro-oncologist and chair of the department of neurology at Memorial Sloan Kettering Cancer Center in New York, about the epidemiology, diagnosis, and treatment of various primary malignant brain tumors in adults. Related Content: Glioblastoma and Other Primary Brain Malignancies in Adults

21.02.2023

•

20 min
21.03.2023

Diagnosis and Management of Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL) affects more than 200 000 people and is associated with >4000 deaths in the US annually. Many people have asymptomatic disease and can be monitored without treatment for long periods. In this podcast, author Mazyar Shadman, MD, MPH, from the University of Washington, Seattle, joins JAMA Deputy Editor Mary M. McDermott, MD, in a discussion about diagnosis and management of CLL. Related Content: Diagnosis and Treatment of Chronic Lymphocytic Leukemia

21.03.2023

•

18 min

JAMA Network™ is a collection of 13 medical journals spanning specialties and general medicine. JN podcasts include Editor summaries, author interviews, conversations, clinical updates and more.